Please use this identifier to cite or link to this item: http://imsear.hellis.org/handle/123456789/183446
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaur, Sukhraj-
dc.contributor.authorMahajan, Mridula-
dc.date.accessioned2017-02-10T11:21:55Z-
dc.date.available2017-02-10T11:21:55Z-
dc.date.issued2016-
dc.identifier.citationKaur Sukhraj, Mahajan Mridula. Fetuin A: A Newer Marker for Pre Diabetes. British Journal of Medicine and Medical Research. 2016; 17(1):1-7.en_US
dc.identifier.issn2231-0614-
dc.identifier.urihttp://imsear.hellis.org/handle/123456789/183446-
dc.description.abstractObjective: To evaluate the role of Fetuin A levels in predicting glycemic outcome in individuals with impaired fasting glucose. Research Design and Methods: A total of 742 young individuals were recruited for the study out of which 177 had impaired fasting glucose, 468 had normoglycemia and 97 individuals with diabetes. These individuals were offsprings of diabetics (either mother or father or both) and were siblings amongst themselves belonging to age group of 18-35 years. Various biochemical investigations such as fasting plasma glucose, glycosylated Hb, serum insulin, C-peptide and Fetuin A were carried out. People with impaired fasting glucose were followed and analyzed according to glycemic outcome and quartile of Fetuin A level. Results: A total of 66 individuals with prediabetes reverted back to normal, 28 progressed to diabetes and 83 remained with prediabetes over a mean±S.D follow up of 24±4.1 months. People in the highest quartile of fetuin A had the highest Insulin, Insulin Resistance, Increased loss of beta cell activity, decreased sensitivity to insulin and a higher rate of progression to diabetes (relative risk 11.96, 95% CI 5.9 to 24.01, p<0.001) and a significantly lower rate of reversion to normoglycemia (relative risk 5.62, 95% CI 3.16 to 9.9, p<0.001) than those in other Fetuin A quartiles. fetuin A correlated positively with Insulin (r= +0.289, p<0.001), C-peptide (r=+ 0.177, p<0.001), %β cell function(r= -0.368, p<0.001), insulin resistance (r= +0.436, p<0.001) and glycosylated Hb (r=+0.958, p<0.05) and negatively with % sensitivity to insulin( r= -0.287, p<0.001). Cox regression analysis showed that baseline fetuin A, insulin levels and fasting glucose levels were predictive of reversion to normoglycemia. Conclusions: Increased fetuin A levels had an adverse impact on glycemic outcomes thus suggesting that fasting plasma glucose and Fetuin A can be used as a tool to determine the susceptibility of an individual to develop pre-diabetes and thus diabetes mellitus.en_US
dc.language.isoenen_US
dc.source.urihttp://www.sciencedomain.org/abstract/15485en_US
dc.subjectFamily historyen_US
dc.subjectpre diabetesen_US
dc.subjectfetuin Aen_US
dc.subjectinsulin resistanceen_US
dc.titleFetuin A: A Newer Marker for Pre Diabetes.en_US
dc.typeArticleen_US
Appears in Collections:British Journal of Medicine and Medical Research

Files in This Item:
File Description SizeFormat 
bjmmr2016v17n1p1-7.pdfOriginal research article140.49 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.